Standardized assay for assessment of minimal residual disease in blood, bone marrow and apheresis from patients with plasma cell myeloma

The recent advances in myeloma treatment result in significantly better outcomes, defined as increased progression free survival (PFS) and overall survival (OS). Since there is a proven correlation between the extend of response and prolonged survival, there is an urgent need for highly sensitive as...

Descripción completa

Detalles Bibliográficos
Autores principales: Blum, Agnieszka, Haussmann, Katy, Streitz, Mathias, Schlickeiser, Stephan, Tietze-Buerger, Carola, Blau, Igor Wolfgang, Uharek, Lutz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393516/
https://www.ncbi.nlm.nih.gov/pubmed/30814612
http://dx.doi.org/10.1038/s41598-019-39631-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393516/
https://www.ncbi.nlm.nih.gov/pubmed/30814612
http://dx.doi.org/10.1038/s41598-019-39631-2

Ejemplares similares